I’ll improve the writing quality, making it clearer and more professional while keeping all your HTML and links intact.
Hyaluronic acid fillers are medical devices used to correct and non-surgically augment various aesthetic imperfections, such as dehydration, dullness, fine lines, and wrinkles. These injectable implants are also perfect for enhancing facial features like thin lips and defining facial contours such as the cheekbones and jawline.
What are the complications of hyaluronic acid fillers?
Despite their effectiveness, patients may still experience complications associated with hyaluronic acid filler implantation, such as swelling, bruising, and tenderness at the injection site. These secondary reactions can be managed if patients are taught basic aftercare methods, such as maintaining proper hygiene at injection sites and protecting the treated area from extreme temperatures.
However, some complications arising from aesthetic implant treatments can be serious and life-threatening. For example, filler that is accidentally injected into a vein or artery can occlude normal blood circulation. If a significant blood-supplying vessel is blocked, the adjacent tissues won’t receive enough blood and oxygen, resulting in necrosis—the irreversible death of skin tissue.
Besides necrosis, blocked blood vessels can cause blood to backflow into the tissues, increasing pressure to the point that low-grade ischemia occurs. One facial region that frequently experiences accidental skin necrosis following hyaluronic acid filler injections is the nose, especially the tip. In extreme cases, poor treatment in the nose area can even lead to blindness if the aesthetic implant is administered into the angular vessels around the nose.
Dermal fillers accidentally injected into the facial artery can travel proximally to the internal carotid system. With the release of pressure, the filler material can then travel into the central retinal artery, causing possible visual impairment or even blindness. Hence, it’s critical that physicians are trained to quickly identify the possible signs of impending necrosis to administer immediate corrective actions and reduce the risk of adverse health reactions.
One such medical intervention is the administration of hyaluronidase, which effectively dissolves the offending hyaluronic acid filler and reverses its effects, both beneficial and adverse.
What is hyaluronidase?
Hyaluronidases refer to a class of injectable enzymes that act as dispersion agents. These enzymes are also produced naturally in the human body and function to break down the natural membranous barriers in tissues. This enzyme has been used to prematurely dissolve hyaluronic acid-based fillers in the event of any health complications after implantation. Many factors—including the strength of the hyaluronic acid-based filler, volume injected, and degree of cross-linking—play a role in determining the sufficient dosage of hyaluronidase.
When should hyaluronidase be administered?
Hyaluronidase can be injected when patients treated with hyaluronic acid-based implants present undesirable side effects, such as unattractive lumps. Those with an unintended “pillow-faced” appearance, where substantial volumes of filler appear visible in the mid-face region, can also be treated with hyaluronidase injections.
Undesirable treatment after-effects can develop on the corrected facial area. Nodules—growths of abnormal tissue that develop within two days of filler injection—can be inflammatory and likely to self-resolve. However, nodules that occur longer-term (within two weeks of treatment) are at risk of worsening (view more about dermal filler removal products).
In addition, blood clots can be managed using hyaluronidase injections. Another unintended side effect of cosmetic filler injection that can be addressed with hyaluronidase is the Tyndall effect—a condition describing the unsightly bluish color of the skin that occurs when filler is injected too superficially.
Another indication requiring hyaluronidase administration is skin blanching, which occurs when the skin appears mottled or dusky after treatment. This change in appearance is typically accompanied by other symptoms, including pain and a cool sensation in the mottled area. Failure to immediately remedy these signs can cause tissue necrosis to occur.
Since this enzyme improves absorption via hypodermoclysis—the process of subcutaneous or interstitial infusion of fluids—it’s best that hyaluronidase not be administered when the healthcare practitioner suspects an infection. Instead, an antibiotic should be prescribed.
Hyaluronidase should be injected the moment complications occur to reduce the severity of complications or prevent the manifestation of tissue necrosis. Early administration of the enzyme also ensures its effectiveness in dissolving hyaluronic acid filler, as the efficacy of the enzyme reduces greatly after approximately four hours.
What is the protocol to administer hyaluronidase?
While there are a few brands of hyaluronidase available on the market, a common preparation widely used is Liporase. This solution for injection is made of 1500 IU of powdered hyaluronidase. This prescription-only medication appears as white powder presented in small vials. Below is the step-by-step process to reconstitute the medication prior to injection:
- Dissolve the hyaluronidase powder with 1ml of chosen solvent (water or normal saline)
- Inject the prepared hyaluronidase solution into the affected areas. Use a 30G needle for superficial injections and a 27G needle for treating deeper skin layers
- When treating nodules, inject the solution directly into the nodules
- When dissolving hyaluronic acid fillers in the superficial dermis layer, inject the solution immediately into and below the injected filler material
- When treating vascular compromise, inject the solution using the serial puncture technique along the length of the vessel. The needle must be positioned perpendicular to the skin. Several injections may be required
Following the administration of hyaluronidase solution, the treated area must be massaged to help with the mechanical breakdown of the filler and enhance the outcome. The procedure listed above must be performed by a certified and experienced physician in accordance with strict aseptic medical standards to reduce the risk of infections.
What are the risks associated with hyaluronidase injections?
Clinical studies have found that one major complication of hyaluronidase injection is allergic reactions, with a frequency of occurrence in approximately 0.05% to 0.69% of cases. Though there is conflicting evidence on whether or not a patch test should be conducted to rule out an allergic reaction, many practitioners agree that a patch test may help minimize the risk of allergic responses. The patch test should be done intradermally (between the skin layers). Physicians should then observe for signs such as erythema, persistent itching, and inflammation.
Patients who develop signs of vascular compromise must be treated using hyaluronidase injection instantly to lower the risk of any life-threatening reactions. Besides breaking down the injected hyaluronic acid material, hyaluronidase injection has the potential to also degrade the body’s natural hyaluronic acid. To lower the risk of this unwanted side effect, aestheticians are recommended to administer the enzyme slowly rather than administering the full dosage at once. If small dosages are inadequate, patients can always return for additional treatments.
Patients should be asked to stay in the clinic for about 30 minutes after being treated with hyaluronidase so they can be observed in a controlled clinical environment for any side effects.
Though the effects of hyaluronidase injection occur almost immediately, highly cross-linked fillers may take up to two days to completely disintegrate. Therefore, physicians should book a follow-up appointment with their patients about two to three weeks after the initial treatment session so that further corrective actions can be administered if necessary.
Conclusion
Hyaluronidase is a valuable medication that works remarkably well in dissolving inaccurately-placed hyaluronic acid-based fillers and managing the resulting complications. Aesthetic practitioners who perform cosmetic injections must be trained in preparing and administering hyaluronidase without delay or doubt should an emergency situation arise. Aesthetic clinics should prepare and regularly review a policy regarding the correct handling of hyaluronidase. Though a patch test is optional, physicians may still perform it, especially in non-urgent cases.
About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.
Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.